Sheng‐xi Wu
Biographic Data
| ID | 3999946 |
|---|---|
| NAME | Sheng‐xi Wu |
| GIVEN NAMES | Sheng‐xi |
| FAMILY NAME | Wu |
| SIGNATURE | WU S X |
| AFFILIATIONS | Shantou Central Hospital |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 20 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1943 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 1 |
Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Pairwise and Network Meta-Analysis of Pathological Complete Response
We performed a pairwise and network meta-analysis to compare pathological complete response (pCR) among neoadjuvant chemotherapy in patients with triple-negative breast cancer. We searched PubMed for randomized clinical trials between January 1, 2000 and December 1, 2020. Abstracts from meetings were also searched. A frequentist random-effect model was applied to compare pCR and toxicities. The P-score was used to rank treatment effects. Nineteen…
Sting-Fish and Seafarer
Systematics and the Origin of Species from the View-Point of a Zoologist
Systematics and the Origin of Species from the View-Point of a Zoologist
Sting-Fish and Seafarer
Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Pairwise and Network Meta-Analysis of Pathological Complete Response
We performed a pairwise and network meta-analysis to compare pathological complete response (pCR) among neoadjuvant chemotherapy in patients with triple-negative breast cancer. We searched PubMed for randomized clinical trials between January 1, 2000 and December 1, 2020. Abstracts from meetings were also searched. A frequentist random-effect model was applied to compare pCR and toxicities. The P-score was used to rank treatment effects. Nineteen…
Biology (2 works) · Breast cancer (1 works) · Breast Cancer Treatment Studies (1 works) · Breast Lesions and Carcinomas (1 works) · Cancer (1 works) · Cancer Treatment and Pharmacology (1 works) · Carboplatin (1 works) · Chemotherapy (1 works) · Cisplatin (1 works) · Engineering (1 works)